Evidence map›Paper›PMID 34273023›Full record

ReviewAmino acids2021

PYCR, a key enzyme in proline metabolism, functions in tumorigenesis.

Yutong Li, Juntao Bie, Chen Song, Minghui Liu, Jianyuan Luo

Abstract readReview
PubMed Publisher
In one paragraph

Review in Amino acids, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Novel Fragment Inhibitors of PYCR1 from Docking-Guided X-ray Crystallography.Journal of chemical information and modeling · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yutong LiDepartment of Medical Genetics, Peking University, 38 Xueyuan Road, Beijing, 100191, China.
Juntao BieDepartment of Medical Genetics, Peking University, 38 Xueyuan Road, Beijing, 100191, China.
Chen SongDepartment of Medical Genetics, Peking University, 38 Xueyuan Road, Beijing, 100191, China.
Minghui LiuDepartment of Medical Genetics, Peking University, 38 Xueyuan Road, Beijing, 100191, China.
Jianyuan LuoDepartment of Medical Genetics, Peking University, 38 Xueyuan Road, Beijing, 100191, China. luojianyuan@bjmu.edu.cn.ORCID http://orcid.org/0000-0001-6057-2914
Peking University · CNCapital Medical University · CN

Funding

National Natural Science Foundation of China 81671389National Natural Science Foundation of China 81874147
6 · The paper itself

Abstract

Pyrroline-5-carboxylate reductase (PYCR), the last enzyme in proline synthesis that converts P5C into proline, was found promoting cancer growth and inhibiting apoptosis through multiple approaches, including regulating cell cycle and redox homeostasis, and promoting growth signaling pathways. Proline is abnormally up-regulated in multiple cancers and becomes one of the critical players in the reprogramming of cancer metabolism. As the last key enzymes in proline generation, PYCRs have been the subject of many investigations, and have been demonstrated to play an indispensable role in promoting tumorigenesis and cancer progression. In this article, we will thoroughly review the recent investigations on PYCRs in cancer development.

Indexed as

AnimalsCarcinogenesisCell CycleHumansNeoplasmsOxidation-ReductionProlinePyrroline Carboxylate ReductasesProlinePyrroline Carboxylate ReductasesCancerProlineProline biogenesisPYCRPyrroline-5-carboxylate reductase

Identifiers

PMID34273023
OpenAlexW3180451487

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.